RecallDepth
Class II Ongoing

Rizatriptan Benzoate Tablets USP, 5mg, 18 (3 X 6) Unit-Dose Tablets, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 Product of India, NDC 68462-465-99

Company
Glenmark Pharmaceuticals Inc., Usa
Recall Initiated
May 10, 2024
Posted
June 12, 2024
Recall Number
D-0532-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
3,480 cartons
Firm Location
Mahwah, NJ, United States

Reason for Recall

CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit.

Distribution

US Nationwide.

Lot / Code Info

Lot#: 19233788; Exp. 9/2025 Lot#: 19224445; Exp. 9/2024

More recalls by Glenmark Pharmaceuticals Inc., Usa

View all recalls by this company →

Other recent Class II Drug recalls